Word

SMALL PHARMA

Status

Pending

Status Code

732

Status Date

Wednesday, January 31, 2024

Serial Number

90523956

Mark Type

3000

Filing Date

Wednesday, February 10, 2021

Published for Opposition

Tuesday, June 7, 2022

Trademark Owner History

CYBIN UK LTD - 1st New Owner After Publication
Small Pharma LTD - Owner At Publication

Classifications

5 Pharmaceutical preparations for treating mental health conditions, depression, anxiety, stress, bipolar affective disorder, body dysmorphia, eating disorders, insomnia, hormonal disorders, sleep disorders, obsessive compulsive disorder, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), psychosis, schizophrenia, dissociative disorders, substance abuse disorders, gambling disorders, neurological conditions and disorders, stroke, Parkinson's disease, Alzheimer's disease, dementia, headaches, migraine, pain conditions, fibromyalgia, neuropathy pain, epilepsy, and non-epileptic seizures; medical preparations for treating mental health conditions, depression, anxiety, stress, bipolar affective disorder, body dysmorphia, eating disorders, insomnia, hormonal disorders, sleep disorders, obsessive compulsive disorder, attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), psychosis, schizophrenia, dissociative disorders, substance abuse disorders, gambling disorders, neurological conditions and disorders, stroke, Parkinson's disease, Alzheimer's disease, dementia, headaches, migraine, pain conditions, fibromyalgia, neuropathy pain, epilepsy, and non-epileptic seizures; neuro-pharmaceutical preparations for treating mental health conditions, depression, anxiety, stress, bipolar affective disorder, body dysmorphia, eating disorders, insomnia, hormonal disorders, sleep disorders, obsessive compulsive disorder, attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), psychosis, schizophrenia, dissociative disorders, substance abuse disorders, gambling disorders, neurological conditions and disorders, stroke, Parkinson's disease, Alzheimer's disease, dementia, headaches, migraine, pain conditions, fibromyalgia, neuropathy pain, epilepsy, and non-epileptic seizures

35 Advertising and marketing; business advisory services relating to the commercial exploitation of inventions; advisory services relating to business management and business operations; providing commercial and business contact information; assistance and advice regarding business organisation and management; business consulting services in the field of product development; wholesale and retail store services featuring pharmaceutical preparations, neuro-pharmaceutical preparations, medical, veterinary and sanitary preparations, apparatus and instruments and medical supplies; compilation of statistical data for use in scientific research for business purposes; compilation of statistical data relating to medical research for business purposes

45 Advisory services relating to intellectual property protection; intellectual property consultancy; intellectual property consultancy services in the field of patents and patent applications; legal consultancy relating to patent mapping; licensing of intellectual property; legal administration of licences; copyright management

44 Pharmaceutical advisory services; pharmaceutical consultation; pharmaceutical compounding services; pharmacy advisory services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; psychological support and mental health therapy services

10 Medical apparatus for use in treating respiratory diseases and conditions; medical devices for use in treating respiratory diseases and conditions; medical apparatus for facilitating the inhalation of pharmaceutical preparations; inhalers for medical use; inhalers for therapeutic use, sold empty; vaporizers for medical purposes; medical apparatus, namely, electric vaporizer for treatment of upper respiratory conditions; nebulizers for administering medication in the form of a mist inhaled into the lungs, for treatment of respiratory diseases and conditions; respiratory masks for medical purposes; medical fluid injectors; needle-based and needle-free injection systems; injection device for pharmaceuticals

42 Consultancy in the field of pharmaceutical research; consultancy in the field of scientific research; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research and development services; testing of pharmaceuticals; scientific laboratory services; scientific advisory services; scientific and industrial research in the field of pharmaceuticals and healthcare; scientific investigations for medical purposes; scientific research services for medical purposes; advisory services relating to scientific research; scientific research in the field of pharmacy; scientific and technological research relating to patent mapping; Scientific and technological services, namely, compiling statistical data in the field of medical and scientific research

The mark consists of a blue hexagon in front of an outline of a blue cloud, with the lower part of the cloud outline appearing inside the hexagon, above the wording "SMALL PHARMA" in blue. All white areas are transparent areas and not part of the mark.
The color(s) blue is/are claimed as a feature of the mark.
"PHARMA"

Trademark Events

Feb 28, 2024

Automatic Update Of Assignment Of Ownership

Feb 26, 2024

Assigned To Examiner

Feb 2, 2024

Notice Of Approval Of Extension Request E-Mailed

Jan 31, 2024

Sou Extension 3 Granted

Jan 31, 2024

Sou Extension 3 Filed

Jan 31, 2024

Sou Teas Extension Received

Aug 2, 2023

Notice Of Approval Of Extension Request E-Mailed

Jul 31, 2023

Sou Extension 2 Granted

Jul 31, 2023

Sou Extension 2 Filed

Jul 31, 2023

Sou Teas Extension Received

Jan 11, 2023

Notice Of Approval Of Extension Request E-Mailed

Jan 9, 2023

Sou Extension 1 Granted

Jan 9, 2023

Sou Extension 1 Filed

Jan 9, 2023

Sou Teas Extension Received

Oct 7, 2022

Teas Change Of Correspondence Received

Oct 7, 2022

Teas Change Of Domestic Representatives Address

Oct 7, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 7, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 2, 2022

Noa E-Mailed - Sou Required From Applicant

Jun 7, 2022

Official Gazette Publication Confirmation E-Mailed

Jun 7, 2022

Published For Opposition

May 18, 2022

Notification Of Notice Of Publication E-Mailed

Apr 29, 2022

Electronic Record Review Complete

Mar 30, 2022

On Hold - Electronic Record Review Required

Mar 14, 2022

Law Office Publication Review Completed

Mar 14, 2022

Approved For Pub - Principal Register

Mar 14, 2022

Examiner's Amendment Entered

Mar 14, 2022

Assigned To Lie

Mar 13, 2022

Notification Of Examiners Amendment E-Mailed

Mar 13, 2022

Examiners Amendment E-Mailed

Mar 13, 2022

Examiners Amendment -Written

Mar 8, 2022

Teas/Email Correspondence Entered

Mar 7, 2022

Correspondence Received In Law Office

Mar 7, 2022

Teas Response To Office Action Received

Sep 8, 2021

Notification Of Non-Final Action E-Mailed

Sep 8, 2021

Non-Final Action E-Mailed

Sep 8, 2021

Non-Final Action Written

Sep 3, 2021

Assigned To Examiner

May 18, 2021

Notice Of Design Search Code E-Mailed

May 15, 2021

New Application Office Supplied Data Entered

Feb 15, 2021

New Application Entered